Our study clarified that ME treatment increased cell cycle G1 phase arrest in pancreatic cancer cells for the first time by disrupting energy homeostasis via the IGFBP-PI3K-mTOR signaling pathway (Fig. 8). The gene discussed is MTOR; the disease is familial pancreatic carcinoma.